Registered entities
Imel Biotherapeutics, Inc.
Reg. No. 36-4930894United States
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Bank & private debt | 1 | 33% |
Developer of cell-based therapies to treat mitochondrial disorders
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Bank & private debt | 1 | 33% |